1. Home
  2. PAVS vs MDXH Comparison

PAVS vs MDXH Comparison

Compare PAVS & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVS
  • MDXH
  • Stock Information
  • Founded
  • PAVS 2004
  • MDXH 2003
  • Country
  • PAVS United States
  • MDXH Belgium
  • Employees
  • PAVS N/A
  • MDXH N/A
  • Industry
  • PAVS Medicinal Chemicals and Botanical Products
  • MDXH
  • Sector
  • PAVS Health Care
  • MDXH
  • Exchange
  • PAVS Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • PAVS 90.2M
  • MDXH 93.1M
  • IPO Year
  • PAVS 2019
  • MDXH 2021
  • Fundamental
  • Price
  • PAVS $1.38
  • MDXH $1.86
  • Analyst Decision
  • PAVS
  • MDXH Strong Buy
  • Analyst Count
  • PAVS 0
  • MDXH 2
  • Target Price
  • PAVS N/A
  • MDXH $7.00
  • AVG Volume (30 Days)
  • PAVS 9.8K
  • MDXH 55.5K
  • Earning Date
  • PAVS 01-01-0001
  • MDXH 02-26-2025
  • Dividend Yield
  • PAVS N/A
  • MDXH N/A
  • EPS Growth
  • PAVS N/A
  • MDXH N/A
  • EPS
  • PAVS N/A
  • MDXH N/A
  • Revenue
  • PAVS $6,544,819.00
  • MDXH $84,708,000.00
  • Revenue This Year
  • PAVS N/A
  • MDXH $28.76
  • Revenue Next Year
  • PAVS N/A
  • MDXH $19.91
  • P/E Ratio
  • PAVS N/A
  • MDXH N/A
  • Revenue Growth
  • PAVS N/A
  • MDXH 33.01
  • 52 Week Low
  • PAVS $0.32
  • MDXH $1.55
  • 52 Week High
  • PAVS $2.48
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • PAVS 59.12
  • MDXH 45.60
  • Support Level
  • PAVS $1.32
  • MDXH $1.73
  • Resistance Level
  • PAVS $1.45
  • MDXH $1.90
  • Average True Range (ATR)
  • PAVS 0.06
  • MDXH 0.08
  • MACD
  • PAVS -0.01
  • MDXH 0.01
  • Stochastic Oscillator
  • PAVS 53.33
  • MDXH 68.00

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: